Search results for " effects"

showing 10 items of 2364 documents

Smokeless tobacco, sport and the heart

2014

SummarySmokeless tobacco (snuff) is a finely ground or shredded tobacco that is sniffed through the nose or placed between the cheek and gum. Chewing tobacco is used by putting a wad of tobacco inside the cheek. Smokeless tobacco is widely used by young athletes to enhance performance because nicotine improves some aspects of physiology. However, smokeless tobacco has harmful health effects, including cardiovascular disorders, linked to nicotine physiological effects, mainly through catecholamine release. Nicotine decreases heart rate variability and the ventricular fibrillation threshold, and promotes the occurrence of various arrhythmias; it also impairs endothelial-dependent vasodilation…

medicine.medical_specialtyNicotineTime FactorsTobacco SmokelessEffets cardiovasculairesTabac non fuméPerformance-Enhancing SubstancesAthletic PerformanceCardiovascular SystemRisk AssessmentNicotineRisk FactorsInternal medicineHeart rateDopingMedicineHeart rate variabilityHumansSnuffNicotinic AgonistsSportDoping in Sportsbusiness.industryHemodynamicsCardiovascular effectsGeneral MedicineSurgerystomatognathic diseasesChewing tobaccoBlood pressureDopageSmokeless tobaccoAthletesSmokeless tobaccoCardiologyMasticationbusinessCardiology and Cardiovascular MedicineAnaerobic exercisemedicine.drugSportsArchives of Cardiovascular Diseases
researchProduct

Placebo and Nocebo Effects Across Symptoms: From Pain to Fatigue, Dyspnea, Nausea, and Itch

2019

Contains fulltext : 208540.pdf (Publisher’s version ) (Open Access) Placebo and nocebo effects are, respectively, the helpful and harmful treatment effects that do not arise from active treatment components. These effects have thus far been researched most often in pain. It is not yet clear to what extent these findings from pain can be generalized to other somatic symptoms. This review investigates placebo and nocebo effects in four other highly prevalent symptoms: dyspnea, fatigue, nausea, and itch. The role of learning mechanisms (verbal suggestions, conditioning) in placebo and nocebo effects on various outcomes (self-reported, behavioral, and physiological) of these different somatic s…

medicine.medical_specialtyNoceboNausealcsh:RC435-571Reviewplacebo and nocebo effectsPlacebo03 medical and health sciences0302 clinical medicinesuggestionconditioninglcsh:PsychiatryHeart ratemedicinepainitchLung functionPsychiatrybusiness.industrydyspneanausea030227 psychiatry3. Good healthNocebo EffectPsychiatry and Mental healthPhysical therapyInflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5]fatigueActive treatmentmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Prenatal manganese serum levels and neurodevelopment at 4 years of age

2020

Abstract Background The excess of manganese (Mn) causes severe deleterious effects in the central nervous system, and the developing brain is especially sensitive to Mn overload. However, results of prospective studies regarding Mn neurodevelopmental effects remain inconclusive. The present study aims at studying the association of prenatal Mn exposure and neurodevelopment at 4–5 years of age. Methods: Mn serum concentration was measured in 1465 pregnant women from the INMA (INfancia y MedioAmbiente, Environment and Childhood) Project. Neurodevelopment was assessed using a standardized version of the McCarthy Scales of Children's Abilities (MSCA). Multivariate regression models were used fo…

medicine.medical_specialtyOffspringPhysiologyPrenatal health010501 environmental sciences01 natural sciencesBiochemistry03 medical and health sciencesChild Development0302 clinical medicinePregnancymedicineHumansProspective Studies030212 general & internal medicineChildProspective cohort study0105 earth and related environmental sciencesGeneral Environmental ScienceManganesePregnancybusiness.industryPublic healthSerum concentrationmedicine.diseaseMicronutrientDietPrenatal Exposure Delayed EffectsFemalebusinessEnvironmental Research
researchProduct

Perinatal high-fat diet increases hippocampal vulnerability to the adverse effects of subsequent high-fat feeding

2015

Epidemiological observations report an increase in fat consumption associated with low intake of n-3 relative to n-6 polyunsaturated fatty acids (PUFAs) in women of childbearing age. However, the impact of these maternal feeding habits on cognitive function in the offspring is unknown. This study aims to investigate the impact of early exposure to a high-fat diet (HFD) with an unbalanced n-6/n-3 PUFAs ratio on hippocampal function in adult rats. Furthermore, we explored the effects of perinatal HFD combined with exposure to HFD after weaning. Dams were fed a control diet (C, 12% of energy from lipids, n-6/n-3 PUFAs ratio: 5) or HFD (HF, 39% of energy from lipids, n-6/n-3 PUFAs ratio: 39) th…

medicine.medical_specialtyOffspringhippocampusEndocrinology Diabetes and MetabolismWeaningHippocampal formationBiologyDiet High-FatmemoryEndocrinologyPregnancyFatty Acids Omega-6Internal medicineLactation[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyFatty Acids Omega-3medicineAnimalsLactationWeaningwater mazeTaqMan low-density arrayRats WistarMaze LearningOmega 3 fatty acidBiological PsychiatrySpatial Memory2. Zero hungerchemistry.chemical_classificationPerinatal ExposureEndocrine and Autonomic Systemsomega-6 fatty acidomega-3 fatty acidfood and beveragesRatsPsychiatry and Mental healthEndocrinologymedicine.anatomical_structureAnimals NewbornchemistryPrenatal Exposure Delayed Effects[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Omega-6 fatty acidFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]lipids (amino acids peptides and proteins)[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyPolyunsaturated fatty acid
researchProduct

Obstetric and offspring risks of women’s morbid conditions linked to prior anticancer treatments

2016

Background Literature shows the effects of type of cancer and/or anticancer treatment on live birth percentages and/or pregnancy and neonatal complications in female cancer survivors. However, studies analyzing the obstetric and offspring risks of the morbid conditions associated with previous anti-cancer treatments are missing. The present review aims to uncover these risks. Methods A literature search based on publications up to March 2016 identified by PubMed and references cited in relevant articles. Results The morbid conditions associated with prior anticancer treatments including chemotherapy, radiotherapy, surgery, and/or hematopoietic stem-cell transplant may induce not only obstet…

medicine.medical_specialtyOffspringmedia_common.quotation_subjectReproductive medicineAntineoplastic AgentsFertilityReview03 medical and health sciences0302 clinical medicineEndocrinologyPregnancyRisk FactorsNeoplasmsmedicineHumansProspective StudiesProspective cohort studymedia_commonPregnancy030219 obstetrics & reproductive medicineRadiotherapyObstetricsbusiness.industryHematopoietic Stem Cell TransplantationObstetrics and GynecologyCancerDelivery Obstetricmedicine.diseaseFertilityTreatment OutcomePregnancy complicationsReproductive MedicineGynecologyPrenatal Exposure Delayed Effects030220 oncology & carcinogenesisGestationFemalebusinessLive birthGestationDevelopmental BiologyReproductive Biology and Endocrinology
researchProduct

Age-related changes in cholesterol metabolism in macrosomic offspring of rats with streptozotocin-induced diabetes.

2001

The aim of this study was to determine the impact of diabetic macrosomia on cholesterol and lipoprotein metabolism. Age-related changes in the activities of serum LCAT, hepatic HMG-CoA reductase, cholesterol 7α-hydroxylase, and ACAT, the major enzymes involved in cholesterol metabolism, were determined in macrosomic offspring of streptozotocin-induced diabetic rats. Hepatic, serum, and lipoprotein cholesterol contents were also examined. Mild hyperglycemia in pregnant rats was induced by intraperitoneal injection of streptozotocin (40 mg/kg body weight) on day 5 of gestation. Control pregnant rats were injected with citrate buffer. At birth, macrosomic pups had higher serum, LDL-HDL1, and H…

medicine.medical_specialtyOffspringmedicine.medical_treatmentLipoproteinsLCATIntraperitoneal injectionQD415-436GrowthReductaseBiologyBiochemistryStreptozocinDiabetes Mellitus ExperimentalFetal MacrosomiaPhosphatidylcholine-Sterol O-Acyltransferasechemistry.chemical_compoundEndocrinologyHMG-CoA reductasePregnancyInternal medicineDiabetes mellitusmedicineAnimalsmacrosomiaRats Wistarmaternal diabetesCholesterol 7-alpha-Hydroxylasecholesterol 7α-hydroxylaseCholesterolCell Biologymedicine.diseaseStreptozotocinAcetyl-CoA C-AcyltransferaseHydroxymethylglutaryl-CoA reductaseACATRatsEndocrinologyCholesterolchemistryLiverHydroxymethylglutaryl-CoA-Reductases NADP-dependentHyperglycemiaPrenatal Exposure Delayed EffectsGestationPregnancy Animallipids (amino acids peptides and proteins)FemaleHydroxymethylglutaryl CoA Reductasesmedicine.drugJournal of lipid research
researchProduct

Iatrogenic pulmonary lesions.

2018

Treatment of patients often includes the administration of medications and sometimes radiation. While the intent is to treat an underlying condition, in some cases, adverse effects occur due to these agents. Most of these adverse effects are mild, however, some can be severe and life-threatening. Furthermore, while these effects are often reversible upon cessation of exposure, especially if the inciting agent is recognized and withdrawn early, others might be permanent or even progressing. Most common histopathologic findings in drug-induced interstitial lung disease include nonspecific interstitial pneumonia (cellular and/or fibrotic), organizing pneumonia with or without bronchiolitis, eo…

medicine.medical_specialtyPathologyDrug-Related Side Effects and Adverse ReactionsPolymersIatrogenic DiseaseAmiodaroneAntineoplastic Agents030204 cardiovascular system & hematologyPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineEarly Medical InterventionmedicineEosinophilic pneumoniaHumansImmunologic FactorsIntensive care medicineDiffuse alveolar damageAdverse effectLungLungRadiotherapybusiness.industryInterstitial lung diseasePulmonary edemamedicine.diseasemedicine.anatomical_structureEquipment and SuppliesNitrofurantoin030220 oncology & carcinogenesisPulmonary hemorrhagebusinessLung Diseases InterstitialAnti-Arrhythmia AgentsHydrophobic and Hydrophilic InteractionsHypersensitivity pneumonitisSeminars in diagnostic pathology
researchProduct

Adherence issues related to sublingual immunotherapy as perceived by allergists.

2010

Silvia Scurati1, Franco Frati1, Gianni Passalacqua2, Paola Puccinelli1, Cecile Hilaire1, Cristoforo Incorvaia3, Italian Study Group on SLIT Compliance 1Scientific and Medical Department, Stallergenes, Milan, Italy; 2Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa; 3Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, ItalyObjectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered…

medicine.medical_specialtyPathologygenetic structuresefficacyAlternative medicineMedicine (miscellaneous)Adherence Cost Efficacy Side effects Sublingual immunotherapySettore MED/10 - Malattie Dell'Apparato Respiratoriosublingual immunotherapyALLERGENcostmedicineSubcutaneous immunotherapySublingual immunotherapyadherenceClinical efficacyIntensive care medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)sublingual immunoterapyOriginal ResearchAsthmaAEROALLERGENSadherence; sublingual immunotherapy; efficacy; cost; side effectsbusiness.industryHealth Policymedicine.diseaseSliteye diseasesClinical trialside effectsPatient Preference and Adherenceadherence; sublingual immunoterapy; efficacy; cost; side effects.immunotherapysense organsAllergistsADHERENCE TO TREATMENTbusinessSocial Sciences (miscellaneous)
researchProduct

Systematic review of the association between particulate matter exposure and autism spectrum disorders

2017

Particulate matter (PM) as an environmental pollutant is suspected to be associated with autism spectrum disorders. The aim of the present study was to review the epidemiological literature currently available on the relation between PM exposure and diagnosis of ASD. The PubMed database was searched from November 2015 up to January 2016 by one of the authors. We included observational studies (cohort and case control studies) published in English carried out in children within the last 10 years, measuring PM exposure and health outcomes related to ASD. 13 studies met the inclusion criteria. Four of the studies found no association between PM exposure and ASD. The other 8 studies show positi…

medicine.medical_specialtyPediatricsAutism Spectrum Disorder010501 environmental sciences01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicinePregnancyStatistical significanceEnvironmental healthEpidemiologymedicineHumansVehicle Emissions0105 earth and related environmental sciencesGeneral Environmental Sciencebusiness.industryPublic healthConfoundingmedicine.diseasePrenatal Exposure Delayed EffectsCohortAutismFemaleParticulate MatterObservational studybusiness030217 neurology & neurosurgeryCohort study
researchProduct

Chelation treatment in sickle-cell-anaemia: much ado about nothing?

2011

Summary Blood transfusions may prevent and treat serious complications related to sickle-cell disease (SCD) when performed according to specific guidelines. However, blood transfusion requirements in SCD inevitably lead to increased body iron burden. An adequate chelation treatment may prevent complications and reduce morbidity and mortality. This review evaluates the effectiveness, safety and costs of chelation treatment. The included trials were examined according to the recommendations of the American College of Cardiology (ACC) and the American Heart Association (AHA). Overall, 14 trials and a total of 502 patients with SCD were included in this review. Deferoxamine alone (s.c. or i.v.)…

medicine.medical_specialtyPediatricsBlood transfusionDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentAnemia Sickle CellDiseaseIron Chelating Agentslaw.inventionBody ironchemistry.chemical_compoundRandomized controlled triallawmedicineHumansChelationIntensive care medicinebusiness.industryDeferasiroxHematologyChelation TherapyDeferoxamineTreatment OutcomechemistryCosts and Cost AnalysisDeferipronebusinessChelation treatment sickle-cell-diseasemedicine.drug
researchProduct